title: [The proceeding of drug development based on the propagation of tau protein].
abstract: Many neurodegenerative diseases accompanied by dementia are associated with the accumulation of protein aggregates. These aggregates are thought to be causes of progressive neurodegeneration and death of neurons. Recent studies indicated that these aggregates could propagate between cells in a prion like manner. Once a protein aggregate is formed it can transmit cell to cell and affect broad regions of brain. Some neurodegenerative diseases such as Alzheimer's disease are associated with the pathological aggregation of tau protein. Thus, these diseases are named as tauopathies. In the brain of these diseases, aggregated tau must also propagate in a prion like manner. Here, we discuss about the therapeutic approaches against dementia based on the prion like propagation of tau proteins.
authors.forename: Genjiro
authors.initials: G
authors.lastname: Suzuki
authors.forename: Masato
authors.initials: M
authors.lastname: Hasegawa
mesh_terms: D017398:Alternative Splicing; D015195:Drug Design; D005091:Exons; D006801:Humans; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D024801:Tauopathies / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism*; D016875:tau Proteins / Q000737:chemistry / Q000378:metabolism*
chemical_list: D020033:Protein Isoforms; D016875:tau Proteins